Cargando…
Model scenarios for cell cycle re-entry in Alzheimer's disease
Alzheimer's disease (AD) is the most prevalent neurodegenerative disease. Aberrant production and aggregation of amyloid beta (Aβ) peptide into plaques is a frequent feature of AD, but therapeutic approaches targeting Aβ accumulation fail to inhibit disease progression. The approved cholinester...
Autores principales: | Pandey, Nishtha, Vinod, P.K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209725/ https://www.ncbi.nlm.nih.gov/pubmed/35747391 http://dx.doi.org/10.1016/j.isci.2022.104543 |
Ejemplares similares
-
BRCA1 May Modulate Neuronal Cell Cycle Re-Entry in Alzheimer Disease
por: Evans, Teresa A., et al.
Publicado: (2007) -
Evidence for the progression through S-phase in the ectopic cell
cycle re-entry of neurons in Alzheimer disease
por: Bonda, David J., et al.
Publicado: (2009) -
DNA Damage Response-Associated Cell Cycle Re-Entry and Neuronal Senescence in Brain Aging and Alzheimer’s Disease
por: Wong, Genper Chi-Ngai, et al.
Publicado: (2023) -
Septal hypertrophy and cell cycle re-entry in AD
por: Butler, Tracy, et al.
Publicado: (2019) -
Gliosis Precedes Amyloid-β Deposition and Pathological Tau Accumulation in the Neuronal Cell Cycle Re-Entry Mouse Model of Alzheimer’s Disease
por: Park, Kevin H.J., et al.
Publicado: (2020)